Efficacy and safety of dimethyl fumarate in patients with moderate-to-severe plaque psoriasis: dimeskin-2, a multicentre single-arm phase iiib study

HIGHLIGHTS

• who: Giovanni Pellacani et al. from the Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy have published the article: Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: DIMESKIN-2, a Multicentre Single-Arm Phase IIIb Study, in the Journal: (JOURNAL)
• what: The aim of this study was to evaluate the efficacy of DMF in adult patients affected by moderate-to-severe chronic plaque psoriasis in terms of the proportion of patients achieving a ≥75% reduction from baseline of the Psoriasis Area and Severity Index . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.